News

February 22, 2022

Quotient Sciences announces that it has integrated drug substance into its flagship Translational Pharmaceutics platform.

February 21, 2022

Recipharm has strengthened its biologics manufacturing capabilities with the acquisition of both Vibalogics and Arranta Bio.

February 21, 2022

The turnkey facilities will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa.

February 18, 2022

Health Canada authorizes Novavax COVID-19 vaccine for individuals 18 years of age and older.

February 18, 2022

PETA Science Consortium International e.V. and PETA scientist Jeffrey Brown share goals with new FDA Commissioner Dr. Robert Califf.

February 18, 2022

FDA has approved Pyrukynd (mitapivat) tablets to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

February 18, 2022

The company has announced plans to establish a commercial presence in six European countries.

February 18, 2022

EC has approved Oxbryta (voxelotor) as a treatment for hemolytic anemia in patients with Sickle Cell Disease (SCD) age 12 years and older.

February 18, 2022

The EC approved AstraZeneca’s Saphenlo (anifrolumab) for the treatment of active autoantibody-positive systemic lupus erythematosus.

February 17, 2022

FDA will hold a symposium discussing the identification of concepts and terminology for multi-component biomarkers from March 23–24, 2022.